| New overdose antidote approved, but concerns raised about cost, side effects The Washington Post (subscription required): Ryan Marino, assistant professor at the School of Medicine, said he favors any medication that will prevent overdose deaths, but worries about the unintended consequences of Opvee—including how it may shape public perceptions of naloxone. “I have a lot of apprehension that now people won’t want naloxone,” he said. |
